1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Precision Cancer Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Hormone Therapy
1.2.3 Immunotherapies
1.2.4 Targeted Therapy
1.2.5 Monoclonal Antibody Therapy
1.2.6 Gene Therapy
1.3 Market by Application
1.3.1 Global Precision Cancer Therapies Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Diagnostic Centers
1.3.4 Oncology Clinics
1.3.5 Research Institutes
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Precision Cancer Therapies Market Perspective (2018-2030)
2.2 Precision Cancer Therapies Growth Trends by Region
2.2.1 Precision Cancer Therapies Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Precision Cancer Therapies Historic Market Size by Region (2018-2023)
2.2.3 Precision Cancer Therapies Forecasted Market Size by Region (2023-2030)
2.3 Precision Cancer Therapies Market Dynamics
2.3.1 Precision Cancer Therapies Industry Trends
2.3.2 Precision Cancer Therapies Market Drivers
2.3.3 Precision Cancer Therapies Market Challenges
2.3.4 Precision Cancer Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Precision Cancer Therapies Players by Revenue
3.1.1 Global Top Precision Cancer Therapies Players by Revenue (2018-2023)
3.1.2 Global Precision Cancer Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Precision Cancer Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Precision Cancer Therapies Revenue
3.4 Global Precision Cancer Therapies Market Concentration Ratio
3.4.1 Global Precision Cancer Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Precision Cancer Therapies Revenue in 2022
3.5 Precision Cancer Therapies Key Players Head office and Area Served
3.6 Key Players Precision Cancer Therapies Product Solution and Service
3.7 Date of Enter into Precision Cancer Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Precision Cancer Therapies Breakdown Data by Type
4.1 Global Precision Cancer Therapies Historic Market Size by Type (2018-2023)
4.2 Global Precision Cancer Therapies Forecasted Market Size by Type (2023-2030)
5 Precision Cancer Therapies Breakdown Data by Application
5.1 Global Precision Cancer Therapies Historic Market Size by Application (2018-2023)
5.2 Global Precision Cancer Therapies Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Precision Cancer Therapies Market Size (2018-2030)
6.2 North America Precision Cancer Therapies Market Size by Country (2018-2023)
6.3 North America Precision Cancer Therapies Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Precision Cancer Therapies Market Size (2018-2030)
7.2 Europe Precision Cancer Therapies Market Size by Country (2018-2023)
7.3 Europe Precision Cancer Therapies Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Precision Cancer Therapies Market Size (2018-2030)
8.2 Asia-Pacific Precision Cancer Therapies Market Size by Country (2018-2023)
8.3 Asia-Pacific Precision Cancer Therapies Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Precision Cancer Therapies Market Size (2018-2030)
9.2 Latin America Precision Cancer Therapies Market Size by Country (2018-2023)
9.3 Latin America Precision Cancer Therapies Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Precision Cancer Therapies Market Size (2018-2030)
10.2 Middle East & Africa Precision Cancer Therapies Market Size by Country (2018-2023)
10.3 Middle East & Africa Precision Cancer Therapies Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Detail
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Precision Cancer Therapies Introduction
11.1.4 Abbott Laboratories Revenue in Precision Cancer Therapies Business (2018-2023)
11.1.5 Abbott Laboratories Recent Development
11.2 Bayer HealthCare
11.2.1 Bayer HealthCare Company Detail
11.2.2 Bayer HealthCare Business Overview
11.2.3 Bayer HealthCare Precision Cancer Therapies Introduction
11.2.4 Bayer HealthCare Revenue in Precision Cancer Therapies Business (2018-2023)
11.2.5 Bayer HealthCare Recent Development
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Detail
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Precision Cancer Therapies Introduction
11.3.4 GlaxoSmithKline Revenue in Precision Cancer Therapies Business (2018-2023)
11.3.5 GlaxoSmithKline Recent Development
11.4 OncoGenex Pharmaceuticals
11.4.1 OncoGenex Pharmaceuticals Company Detail
11.4.2 OncoGenex Pharmaceuticals Business Overview
11.4.3 OncoGenex Pharmaceuticals Precision Cancer Therapies Introduction
11.4.4 OncoGenex Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023)
11.4.5 OncoGenex Pharmaceuticals Recent Development
11.5 Hospira
11.5.1 Hospira Company Detail
11.5.2 Hospira Business Overview
11.5.3 Hospira Precision Cancer Therapies Introduction
11.5.4 Hospira Revenue in Precision Cancer Therapies Business (2018-2023)
11.5.5 Hospira Recent Development
11.6 Boehringer Ingelheim
11.6.1 Boehringer Ingelheim Company Detail
11.6.2 Boehringer Ingelheim Business Overview
11.6.3 Boehringer Ingelheim Precision Cancer Therapies Introduction
11.6.4 Boehringer Ingelheim Revenue in Precision Cancer Therapies Business (2018-2023)
11.6.5 Boehringer Ingelheim Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Detail
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Precision Cancer Therapies Introduction
11.7.4 AstraZeneca Revenue in Precision Cancer Therapies Business (2018-2023)
11.7.5 AstraZeneca Recent Development
11.8 Aveo Pharmaceuticals
11.8.1 Aveo Pharmaceuticals Company Detail
11.8.2 Aveo Pharmaceuticals Business Overview
11.8.3 Aveo Pharmaceuticals Precision Cancer Therapies Introduction
11.8.4 Aveo Pharmaceuticals Revenue in Precision Cancer Therapies Business (2018-2023)
11.8.5 Aveo Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
